Psychedelic Alpha has an interesting leak/”insider rumor” regarding the sector company AtaiBeckley. The original leak to Bloomberg was in March, and it seems to be heating up now:
” Sources Say AtaiBeckley Deal Close to Completion
In Q1, rumours of a potential partnering deal concerning AtaiBeckley’s lead candidate, BPL-003 (intranasal 5-MeO-DMT for treatment-resistant depression) swirled, as we reported in March.
Since then, it’s been crickets; at least publicly. But people familiar with the matter told Psychedelic Alpha that news should come soon, with a potential announcement this month.
There are three kinds of offer on the table, the sources told us, including a full takeover of the company, codevelopment of BPL-003 alone, and a royalty investment deal. AtaiBeckley’s board is currently weighing these offers, they said.
The dealmaking process may have been buoyed by Definium’s positive market momentum. Indeed, at least one pharma player came to the table right after the LSD drug developer’s Phase 3 readout, we understand.”
In my estimation, Psychedelic Alpha is a reliable and well-networked source of information, and I look forward to seeing what comes of it. Yesterday, at the opening, I moved my adjusted funds back into ATAI from Compass…